Total Payments
$1,011
2020 Payments
$27.39
Companies
6
Transactions
75
Medicare Patients
174
Medicare Billing
$13,675
Payment Breakdown by Category
Food & Beverage$861.16 (85.2%)
Consulting$150.00 (14.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $861.16 | 74 | 85.2% |
| Consulting Fee | $150.00 | 1 | 14.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $432.71 | 23 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $315.63 | 24 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $162.42 | 22 | $0 (2019) |
| Allergan Inc. | $67.54 | 4 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $17.30 | 1 | $0 (2017) |
| Neurocrine Biosciences, Inc. | $15.56 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $27.39 | 2 | Janssen Pharmaceuticals, Inc ($27.39) |
| 2019 | $241.10 | 17 | Janssen Pharmaceuticals, Inc ($130.30) |
| 2018 | $312.02 | 25 | Alkermes, Inc. ($151.31) |
| 2017 | $430.65 | 31 | Alkermes, Inc. ($195.57) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/24/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA, INVEGA TRINZA | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: Neuroscience | ||||||
| 01/31/2020 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), SPRAVATO | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Neuroscience | ||||||
| 12/17/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Neuroscience | ||||||
| 11/15/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA, INVEGA TRINZA | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Neuroscience | ||||||
| 10/14/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), SPRAVATO | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Neuroscience | ||||||
| 10/04/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: PSYCHIATRY | ||||||
| 09/23/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: CNS | ||||||
| 09/20/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA, INVEGA TRINZA | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Neuroscience | ||||||
| 08/30/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: PSYCHIATRY | ||||||
| 08/24/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA, INVEGA TRINZA | Food and Beverage | In-kind items and services | $7.18 | General |
| Category: Neuroscience | ||||||
| 08/16/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: CNS | ||||||
| 06/14/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA, INVEGA TRINZA | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Neuroscience | ||||||
| 05/20/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Neuroscience | ||||||
| 05/09/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: CNS | ||||||
| 04/12/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Neuroscience | ||||||
| 03/29/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: CNS | ||||||
| 03/18/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Neuroscience | ||||||
| 02/15/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Neuroscience | ||||||
| 01/22/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Neuroscience | ||||||
| 12/14/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Neuroscience | ||||||
| 12/12/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: CNS | ||||||
| 12/12/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $0.31 | General |
| Category: CNS | ||||||
| 11/30/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: NEUROLOGY | ||||||
| 11/16/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Neuroscience | ||||||
| 11/07/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 3 | 174 | 262 | $47,800 | $13,675 |
Total Patients
174
Total Services
262
Medicare Billing
$13,675
Procedure Codes
3
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 101 | 157 | $27,450 | $9,272 | 33.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 57 | 82 | $12,300 | $3,157 | 25.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 16 | 23 | $8,050 | $1,246 | 15.5% |
About Dr. Glenn Webb, MD
Dr. Glenn Webb, MD is a Psychiatry healthcare provider based in Mc Minnville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538240130.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Glenn Webb, MD has received a total of $1,011 in payments from pharmaceutical and medical device companies, with $27.39 received in 2020. These payments were reported across 75 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($861.16).
As a Medicare-enrolled provider, Webb has provided services to 174 Medicare beneficiaries, totaling 262 services with total Medicare billing of $13,675. Data is available for 1 year (2020–2020), covering 3 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Mc Minnville, TN
- Active Since 10/18/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1538240130
Products in Payments
- INVEGA SUSTENNA (Drug) $251.99
- Aristada 441 mg (Drug) $186.17
- ABILIFY MAINTENA (Drug) $162.42
- ARISTADA (Drug) $85.83
- VRAYLAR (Drug) $67.54
- SPRAVATO (Drug) $63.64
- APTIOM (Drug) $17.30
- INGREZZA (Drug) $15.56
- Vivitrol 380 mg (Drug) $10.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.